Tag: Human Papillomavirus (HPV)
Vaginal Cancer Incidence Increasing Globally
Risk factors include unsafe sex and HIV infection
Guidelines Address RT for Management of HPV-Linked Oropharyngeal Cancer
Tailored recommendations presented to maximize survival and minimize side effects
At-School Vaccination Boosts HPV Vaccination Coverage
No significant effect seen for increasing adolescent, parent, and provider education
Quality Improvement Initiative Boosts Early HPV Vaccine Rates
Findings show significant increases across racial/ethnic, sociodemographic, insurance, and geographic groups
FDA Approves First Self-Test Collection Kit for HPV
AACR: At-Home HPV Testing Boosts Cervical Cancer Screening Participation
Combining self-sampling with phone-based patient navigation further increases screening participation
Disparities Seen in HPV Vaccine Uptake Among U.S. Adults
Men, Hispanic adults have lower odds of receiving the vaccine
Advantaged Households Have Lower Intent to Vaccinate Teens Against HPV
Safety concerns were primary reason for parents in the advantaged group to have no intention to vaccinate
No Increase Seen in HPV Vaccination Coverage From 2019 to 2022
Higher coverage seen for lesbian, gay, bisexual, other sexual orientation versus heterosexual women; for gay, bisexual, other versus heterosexual men
38.6 Percent of 9- to 17-Year-Olds Have Received at Least One HPV Vaccine Dose
Likelihood of receiving HPV vaccine dose higher for children with private health insurance and for those with disability
